Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
10/2006
10/11/2006EP1708994A1 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics
10/11/2006EP1708811A1 Catalyst for synthesis of 2-and 4-picolines, process for preparing 2- and 4-picoline and process for preparing the catalyst
10/11/2006EP1708698A1 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders
10/11/2006CN1845980A 电致发光装置 Electroluminescent devices
10/11/2006CN1845921A Adamantane and azabicyclo-octane and nonane derivatives, process of their preparation and their use as DPP-IV inhibitors
10/11/2006CN1845915A Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5
10/11/2006CN1845673A Pyridinylanilides
10/11/2006CN1844100A Process for preparing Torasemide intermediate and its analogue
10/10/2006US7119221 treating and preventing a variety of diseases and conditions such as aging, Alzheimer's Disease, cancer, cardiovascular disease, diabetic retinopathy, dyslipidemia, dyslipoproteinemia, hypertension, impotence, insulin resistance, peroxisome proliferator activated receptor associated disorders
10/10/2006US7119204 phenanthroline compounds that exhibit electroluminescence, photoluminescence and/or photosensitivity, used in electrical apparatus such as organic light emitting diodes
10/10/2006US7119203 Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
10/10/2006US7119122 Compounds for the inhibition of nitric oxide synthase
10/10/2006US7119110 Method and composition for preventing or reducing the symptoms of insulin resistance syndrome
10/10/2006US7119109 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase
10/10/2006US7119098 Antitumor agents; osteoporosis; antiarthritic agents; oral diseases
10/10/2006US7119080 Boronic ester and acid compounds, synthesis and uses
10/10/2006US7118899 Introducing a reagent comprising a hydrophobic fluorescent ion; measuring energy transfer
10/10/2006CA2268799C Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cosmetic compositions containing same
10/05/2006WO2006105127A2 Hydroxysteroid dehydrogenase inhibitors
10/05/2006WO2006105076A2 Processes for preparing monomer complexes
10/05/2006WO2006105023A1 Pyridine derivatives useful as inhibitors of pkc-theta
10/05/2006WO2006104141A1 3-propenylcephem derivative
10/05/2006WO2006103503A1 Substituted aryloxoethyl cyclopropanecarboxamide compounds as vr1 receptor antagonists
10/05/2006WO2006103463A1 Iron modulators
10/05/2006WO2006103342A2 Indanyl-piperazine derivatives, method for preparing same and pharmaceutical compositions containing same
10/05/2006WO2006091800A3 Novel pyridine derivatives as potassium ion channel openers
10/05/2006WO2006091796A3 Compositions and methods for diagnosing and treating retinal diseases
10/05/2006WO2006078621A3 2-phenoxy-n- (1, 3 , 4-thiadizol-2-yl) pyridin-3-amine derivatives and related compounds as p2y1 receptor inhibitors for the treatment of thromboembolic disorders
10/05/2006WO2006077387A3 Novel benzamide derivatives
10/05/2006WO2006011050A3 Pyridine derivatives
10/05/2006WO2005116198A3 Methods of 1,3-enyne preparation using copper (i) catalysts
10/05/2006WO2004060308A3 Thiosemicarbazones as anti-virals and immunopotentiators
10/05/2006US20060223995 Superhigh purity ionic liquid
10/05/2006US20060223853 e.g. 1-[2-hydroxy-3-(quinolin-5-yloxy)-propyl]-piperidine-4-carboxylic acid [4-phenyl-1-(3-phenyl-propyl)-butyl]-amide; multidrug resistance protein or P-glycoprotein modulator; with other therapeutic agent: anticarcinogenic, antibacterial, antiviral, antifungal agents
10/05/2006US20060223800 Pyrazolopyridines and pyrazolopyridazines adn antidiabetics
10/05/2006US20060222584 Salts comprising cyanoborate anions
10/05/2006US20060220004 with Tris(2-bromo-6-pyridyl)phosphine oxide ligands; organic light-emitting diodes, integrated circuits, organic field-effect transistors, thin-film transistors, organic solar cells, and/or laser diodes
10/05/2006DE102005014822A1 Verfahren zur Herstellung aromatischer Aldehyde A process for preparing aromatic aldehydes
10/05/2006CA2602566A1 Substituted aryloxoethyl cyclopropanecarboxamide compounds as vr1 receptor antagonists
10/05/2006CA2602250A1 Pyridine derivatives useful as inhibitors of pkc-theta
10/04/2006EP1707564A2 Indanyl-piperazine derivatives, process for their preparation and pharmaceutical compositions containing them
10/04/2006EP1707560A1 Hydroxamic acid derivative and age generation inhibitor containing the derivative
10/04/2006EP1707548A1 Method of deuteration using mixed catalyst
10/04/2006EP1706402A1 Cathepsin cysteine protease inhibitors
10/04/2006EP1706396A1 N-(4-carbamimidoyl-benzyl)-2-alkoxy-2-heterocyclyl acetamides as inhibitors of the formation of coagulation factors xa, ixa and thrombin induced by factor viia
10/04/2006EP1706382A1 Method for stabilizing 4-halogenpyridines with secondary and/or tertiary amines
10/04/2006EP1706381A2 Process for the manufacture of 2,3-dichloropyridine
10/04/2006EP1706372A1 Alpha-hydroxy amides as bradykinin antagonists or inverse agonists
10/04/2006EP1543014B1 Preparation of metal complexes
10/04/2006EP1534658A4 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
10/04/2006EP1377290B1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
10/04/2006EP0906091B1 Amidinohydrazones as protease inhibitors
10/04/2006CN1842272A Hydrazone derivatives for combatting harmful insects and arachnids
10/04/2006CN1277824C Piperazine derivatives
10/04/2006CN1277545C Use of bisphosphonates in preparing medicine for the treatment of bone metastasis associated with prostate cancer
10/04/2006CN1277528C Dyeing composition for kerationous fibres comprising particular dicationic diazo dye
10/03/2006US7115784 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/03/2006US7115769 Catalyzing the alkylation, forming a 2-alkylcysteine derivatives, a chemical intermediates for iron chelating agents
10/03/2006US7115768 Particularly (adamantylcarbonylamino)acetic acid derivatives
10/03/2006US7115752 Substituted cyclic compounds
10/03/2006US7115750 Melanin concentrating hormone antagonist
10/03/2006US7115746 Processes for the facile synthesis of diaryl amines and analogues thereof
10/03/2006US7115666 Analgesics; trauma brain injuries ; antiarthritic agents
10/03/2006US7115664 Peptidomimetic ligands for cellular receptors and ion channels
10/03/2006US7115654 Caspase-1 inhibitors and methods for their use
10/03/2006US7115652 Aspartyl protease inhibitors
10/03/2006US7115637 Inhibitors of p38
10/03/2006US7115627 Trypsin-like serine protease enzyme inhibitors; anticoagulants
10/03/2006US7115618 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication
10/03/2006US7115611 Phenyl derivatives, their manufacture and use as pharmaceutical agents
10/03/2006US7115608 Pyridinone and pyridinethione derivatives having HIV inhibiting properties
10/03/2006US7115607 Substituted piperazinyl amides and methods of use
10/03/2006US7115605 Peptide deformylase inhibitors
10/03/2006US7115600 Histamine-3 receptor modulators
10/03/2006US7115401 Using hydrophobic fluorescent ion capable of redistributing from a first face of the membrane to a second face of the membrane in response to changes in the membrane potential
10/03/2006CA2189221C Substituted sulfonimidamides, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them
09/2006
09/28/2006WO2006102645A1 Biaryl derived amide modulators of vanilloid vr1 receptor
09/28/2006WO2006101144A1 Charge control agent and related technique
09/28/2006WO2006100502A1 11-beta-hydroxysteroid dehydrogenase inhibitors
09/28/2006WO2006100039A1 Carboxanilides as microbiocides
09/28/2006WO2006099968A1 Metabolites for nk-i antagonists for emesis
09/28/2006WO2006099684A1 Copper complexes
09/28/2006WO2006074244A3 Adamantyl derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
09/28/2006WO2006060731A3 Use of atazanavir for improving the pharmacokinetics of drugs metabolized by ugt1a1
09/28/2006WO2006044975A3 Compositions and their use as anti-tumor agents
09/28/2006WO2006025979A3 Modulators of nuclear receptors
09/28/2006WO2005064008A9 Method and compositions for identifying anti-hiv therapeutic compounds
09/28/2006WO2005013914A8 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain
09/28/2006US20060217561 Synthesis of substituted thiazoline carboxylic acids
09/28/2006US20060217558 Method for producing 1, 3-dialkylpyridinium oligomers and related compounds using a solid support
09/28/2006US20060217433 Sulfonamide derivatives as ppar modulators
09/28/2006US20060217426 Compound inhibiting in vivo phosphorous transport and medicine containing the same
09/28/2006US20060217424 Compounds for the inhibition of nitric oxide synthase
09/28/2006US20060217412 Imidazo-fused oxazolo[4,5-b]pyridine and imidazo-fused thiazolo[4,5-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising same
09/28/2006US20060217403 Substituted 2-aminoacetamides and the use thereof
09/28/2006US20060217398 Substituted pyrimidine derivatives
09/28/2006US20060217379 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
09/28/2006US20060217373 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same
09/28/2006US20060217372 Diaryl ethers as opioid receptor antagonist
09/28/2006US20060217349 Having antiinflammatory, anti-pyretic and anti-diarrheal properties